Allogene Therapeutics
ALLO
ALLO
170 hedge funds and large institutions have $398M invested in Allogene Therapeutics in 2023 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 50 increasing their positions, 52 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
4% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 52
4.09% less ownership
Funds ownership: 77.73% → 73.64% (-4.1%)
79% less call options, than puts
Call options by funds: $96K | Put options by funds: $451K
Holders
170
Holding in Top 10
2
Calls
$96K
Puts
$451K
Top Buyers
| 1 | +$6.27M | |
| 2 | +$6.19M | |
| 3 | +$5.76M | |
| 4 |
BlackRock
New York
|
+$3.56M |
| 5 |
Two Sigma Investments
New York
|
+$3.26M |
Top Sellers
| 1 | -$18.5M | |
| 2 | -$14.2M | |
| 3 | -$8.78M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$5M |
| 5 |
Rafferty Asset Management
New York
|
-$2.17M |